Efficacy and Safety of Tran Cannula in Combined Pseudoexfoliative Glaucoma and Cataract Surgery Compared With Augmented Ocular Irrigation
Condition(s) studied
Investigational drug(s) / intervention(s)
Tran canula: After phacoemulsification, implantation of the intraocular implant and aspiration of the viscoelastic, we connect the TranCanula® to the irrigation system. Then we treat the trabecular mesh.
augmented irrigation: After phacoemulsification, We use the classical aspiration cannula to irrigate the trabecular mesh.
Study summary
Pseudoexfoliative glaucoma is a glaucoma secondary to pseudoexfoliative syndrome; cataract surgery is often more difficult, with more complications. Tran's cannula is a single-use irrigation system designed for cleaning, with the pseudoexfoliative material remaining in the trabecular meshwork.
The main objective of this study is to evaluate the efficacy of the Tran cannula, in comparison with increased irrigation, in lowering intraocular pressure (IOP) in patients with pseudoexfoliative glaucoma and treated for glaucoma, and with an indication for isolated cataract surgery.
Eligibility
Primary outcome measure(s)
- Intraocular pressure measure — day 1, day 30, month 3, month 6 and month 12 after surgery
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital Privé de la Baie | Avranches | France | Recruiting |
| Fondation Rothschild | Paris | France | Active Not Recruiting |
| Clinique de la Côte d'Emeraude | St-Malo | France | Not Yet Recruiting |
More Hôpital Privé de la Baie trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06979752 on ClinicalTrials.gov ↗ ← All trials in France